scholarly article | Q13442814 |
P50 | author | K Rivet Amico | Q58238816 |
Carol Bova | Q59144251 | ||
P2093 | author name string | Ann Bartley Williams | |
Julie A Womack | |||
P2860 | cites work | Statistical methods for assessing agreement between two methods of clinical measurement | Q26778461 |
Adherence to HAART therapy measured by electronic monitoring in newly diagnosed HIV patients in Botswana | Q28221847 | ||
Responses to a 1 month self-report on adherence to antiretroviral therapy are consistent with electronic data and virological treatment outcome | Q30670830 | ||
Adjusting and censoring electronic monitoring device data. Implications for study outcomes | Q31081014 | ||
Examining assumptions regarding valid electronic monitoring of medication therapy: development of a validation framework and its application on a European sample of kidney transplant patients | Q33320339 | ||
Lack of association between retrospectively collected pharmacy refill data and electronic drug monitoring of antiretroviral adherence | Q33393729 | ||
An examination of the psychometric properties of the Antiretroviral General Adherence Scale (AGAS) in two samples of HIV-infected individuals | Q33679085 | ||
Attaining higher goals in HIV treatment: the central importance of adherence | Q33765198 | ||
Reciprocal prediction of medication adherence and neurocognition in HIV/AIDS. | Q33834254 | ||
Practical and conceptual challenges in measuring antiretroviral adherence | Q33835857 | ||
Self-report measures of antiretroviral therapy adherence: A review with recommendations for HIV research and clinical management | Q33851716 | ||
Adherence: a necessity for successful HIV combination therapy. | Q33961694 | ||
Adherence in chronic disease | Q33986619 | ||
The consistency of adherence to antiretroviral therapy predicts biologic outcomes for human immunodeficiency virus-infected persons in clinical trials | Q34120588 | ||
Real-time adherence monitoring for HIV antiretroviral therapy | Q34284065 | ||
Predictors of HIV drug-resistance mutations in a large antiretroviral-naive cohort initiating triple antiretroviral therapy | Q34381830 | ||
Pharmacy adherence measures to assess adherence to antiretroviral therapy: review of the literature and implications for treatment monitoring | Q34699180 | ||
An analysis of electronically monitored adherence to antiretroviral medications | Q35161647 | ||
Methods for evaluation of medication adherence and persistence using automated databases | Q36412470 | ||
Adherence to antiretroviral therapy assessed by unannounced pill counts conducted by telephone | Q36416650 | ||
Measurement of adherence in pharmacy administrative databases: a proposal for standard definitions and preferred measures | Q36547005 | ||
Improving the self-report of HIV antiretroviral medication adherence: is the glass half full or half empty? | Q36951006 | ||
Use of electronic monitoring in clinical nursing research | Q36973993 | ||
Antiretroviral therapy adherence and viral suppression in HIV-infected drug users: comparison of self-report and electronic monitoring | Q37217490 | ||
Antiretroviral failure despite high levels of adherence: discordant adherence-response relationship in Botswana | Q37340992 | ||
Importance of dose timing to achieving undetectable viral loads | Q37379594 | ||
Relationship of prospective memory to neuropsychological function and antiretroviral adherence | Q37393648 | ||
Assessing antiretroviral adherence via electronic drug monitoring and self-report: an examination of key methodological issues | Q37395005 | ||
Timing is everything: antiretroviral nonadherence is associated with impairment in time-based prospective memory | Q37419533 | ||
The social realities of adherence to protease inhibitor regimens: substance use, health care and psychological states | Q38473145 | ||
Adherence to antiretroviral therapy in a home-based AIDS care programme in rural Uganda | Q38878886 | ||
Multiple validated measures of adherence indicate high levels of adherence to generic HIV antiretroviral therapy in a resource-limited setting | Q38881891 | ||
Adherence to highly active antiretroviral therapy predicts virologic outcome at an inner-city human immunodeficiency virus clinic | Q39575431 | ||
Adherence to protease inhibitor therapy and outcomes in patients with HIV infection | Q39605935 | ||
Pharmacy-based assessment of adherence to HAART predicts virologic and immunologic treatment response and clinical progression to AIDS and death | Q39702981 | ||
The elusive gold standard. Future perspectives for HIV adherence assessment and intervention | Q40265692 | ||
The value of patient-reported adherence to antiretroviral therapy in predicting virologic and immunologic response. California Collaborative Treatment Group | Q40806729 | ||
The assessment of refill compliance using pharmacy records: methods, validity, and applications | Q41361915 | ||
HIV therapeutics: confronting adherence | Q41632789 | ||
Self-reported adherence to antiretroviral medications among participants in HIV clinical trials: the AACTG adherence instruments. Patient Care Committee & Adherence Working Group of the Outcomes Committee of the Adult AIDS Clinical Trials Group (AAC | Q41752733 | ||
A practical method to calibrate self-reported adherence to antiretroviral therapy | Q43512109 | ||
Virologic outcome and predictors of virologic failure of highly active antiretroviral therapy containing protease inhibitors. | Q43612758 | ||
Optimal recall period and response task for self-reported HIV medication adherence | Q43753135 | ||
Evaluating adherence to highly active antiretroviral therapy with use of pill counts and viral load measurement in the drug resources enhancement against AIDS and malnutrition program in Mozambique | Q43811493 | ||
Evaluation of noncompliance in schizophrenia patients using electronic monitoring (MEMS) and its relationship to sociodemographic, clinical and psychopathological variables | Q44193921 | ||
Correlates of self-reported nonadherence to antiretroviral therapy in HIV-infected patients: the Swiss HIV Cohort Study | Q44524787 | ||
Adherence to highly active antiretroviral therapy in the homeless population in San Francisco: a prospective study | Q45108750 | ||
Characterizing patterns of drug-taking behavior with a multiple drug regimen in an AIDS clinical trial | Q46212340 | ||
Relationship between adherence and the development of resistance in antiretroviral-naive, HIV-1-infected patients receiving lopinavir/ritonavir or nelfinavir | Q46494163 | ||
Measuring adherence to antiretroviral therapy in a diverse population using a visual analogue scale | Q46572937 | ||
Electronic monitoring device event modelling on an individual-subject basis using adaptive Poisson regression | Q47188648 | ||
Use of electronic monitoring devices to measure antiretroviral adherence: practical considerations. | Q51509651 | ||
A measurement model of medication adherence to highly active antiretroviral therapy and its relation to viral load in HIV-positive adults. | Q51930660 | ||
Bayes and health care research. | Q51979450 | ||
A comparison study of multiple measures of adherence to HIV protease inhibitors. | Q52062736 | ||
Adherence, compliance, and HAART. | Q53966618 | ||
Diagnostic Value of Different Adherence Measures Using Electronic Monitoring and Virologic Failure as Reference Standards | Q56778249 | ||
Use of Electronic Monitoring Induces a 40-Day Intervention Effect in HIV Patients | Q56778338 | ||
Differential impact of adherence on long-term treatment response among naive HIV-infected individuals | Q57259643 | ||
Validity of Self-Reported Adherence Among Injection Drug Users | Q57259665 | ||
A randomized comparison of two instruments for measuring self-reported antiretroviral adherence | Q58106370 | ||
Adherence to Antiretroviral Medication Among HIV-Positive Patients in Thailand | Q58275507 | ||
Self-Reported Adherence to Antiretroviral Therapy for HIV-1 Infection and Virologic Treatment Response | Q58478514 | ||
Long-term utility of measuring adherence by self-report compared with pharmacy record in a routine clinic setting | Q59647423 | ||
Public Health Implications of Antiretroviral Therapy and HIV Drug Resistance | Q59700719 | ||
Impact of adherence and highly active antiretroviral therapy on survival in HIV-infected patients | Q74239445 | ||
Assessment of adherence to HIV protease inhibitors: comparison and combination of various methods, including MEMS (electronic monitoring), patient and nurse report, and therapeutic drug monitoring | Q74493692 | ||
Accuracy of a provincial prescription database for assessing medication adherence in heart failure patients | Q80781080 | ||
A time-to-prescription-refill measure of antiretroviral adherence predicted changes in viral load in HIV | Q80967260 | ||
Correction for errors in measuring adherence to prenatal multivitamin/mineral supplement use among low-income women | Q82310699 | ||
Patients' self-reported adherence to cardiovascular medication using electronic monitors as comparators | Q83040872 | ||
Using different calculations of pharmacy refill adherence to predict virological failure among HIV-infected patients | Q84968345 | ||
Self-reported adherence is more predictive of virological treatment response among patients with a lower tendency towards socially desirable responding | Q85017689 | ||
P433 | issue | 1 | |
P304 | page(s) | 284-297 | |
P577 | publication date | 2013-01-01 | |
P1433 | published in | AIDS and Behavior | Q15752229 |
P1476 | title | A proposal for quality standards for measuring medication adherence in research | |
P478 | volume | 17 |
Q36943508 | A New Frontier: Integrating Behavioral and Digital Technology to Promote Health Behavior |
Q37486409 | A Self-Reported Adherence Measure to Screen for Elevated HIV Viral Load in Pregnant and Postpartum Women on Antiretroviral Therapy |
Q99418164 | A data-driven typology of asthma medication adherence using cluster analysis |
Q35558205 | Accuracy of Self-Report and Pill-Count Measures of Adherence in the FEM-PrEP Clinical Trial: Implications for Future HIV-Prevention Trials |
Q57136315 | Actionable Adherence Monitoring: Technological Methods to Monitor and Support Adherence to Antiretroviral Therapy |
Q35538913 | Adherence in the treatment of patients with extensively drug-resistant tuberculosis and HIV in South Africa: a prospective cohort study |
Q47550476 | Adherence to antiretroviral therapy for HIV/AIDS in Latin America and the Caribbean: Systematic review and meta-analysis. |
Q37242342 | Adherence to immunosuppressive therapy following liver transplantation: an integrative review |
Q38854507 | Alcohol Interactive Toxicity Beliefs and ART Non-adherence Among HIV-Infected Current Drinkers in Mbarara, Uganda |
Q38434065 | Assessing adherence to multiple medications and in daily life among patients with multimorbidity |
Q38156105 | Assessing medication adherence: options to consider |
Q38944299 | Association between self-reported adherence and HIV viral load suppression among older children and adolescents |
Q59340209 | Associations between perceived barriers and benefits of using HIV pre-exposure prophylaxis and medication adherence among men who have sex with men in Western China |
Q38063174 | Cognitive interviewing for cross-cultural adaptation of pediatric antiretroviral therapy adherence measurement items |
Q91274143 | Comparison of Different Strategies to Measure Medication Adherence via Claims Data in Patients With Chronic Heart Failure |
Q33713856 | Comparison of adherence monitoring tools and correlation to virologic failure in a pediatric HIV clinical trial |
Q37736861 | Comparison of six methods to estimate adherence in an ART-naïve cohort in a resource-poor setting: which best predicts virological and resistance outcomes? |
Q36356513 | Computation of adherence to medication and visualization of medication histories in R with AdhereR: Towards transparent and reproducible use of electronic healthcare data. |
Q47272447 | Concordance of Adherence Measurement Using Self-Reported Adherence Questionnaires and Medication Monitoring Devices: An Updated Review |
Q36030946 | Concordance of Direct and Indirect Measures of Medication Adherence in A Treatment Trial for Cannabis Dependence |
Q35408032 | Contingency management facilitates the use of postexposure prophylaxis among stimulant-using men who have sex with men |
Q40335852 | Correlation of Adherence by Pill Count, Self-report, MEMS and Plasma Drug Levels to Treatment Response Among Women Receiving ARV Therapy for PMTCT in Kenya |
Q36710299 | Current concepts for PrEP adherence in the PrEP revolution: from clinical trials to routine practice |
Q35780443 | Defining success with HIV pre-exposure prophylaxis: a prevention-effective adherence paradigm |
Q35956767 | Desirability and feasibility of wireless electronic monitoring of medications in clinical trials |
Q39544268 | Development of an algorithm for analysing the electronic measurement of medication adherence in routine HIV care |
Q34085477 | Dual quantification of dapivirine and maraviroc in cervicovaginal secretions from ophthalmic tear strips and polyester-based swabs via liquid chromatographic-tandem mass spectrometric (LC-MS/MS) analysis |
Q38966648 | ESPACOMP Medication Adherence Reporting Guidelines (EMERGE): a reactive-Delphi study protocol |
Q38191840 | Electronic measurement of medication adherence |
Q40239354 | Evaluation of a Multidrug Assay for Monitoring Adherence to a Regimen for HIV Preexposure Prophylaxis in a Clinical Study, HIV Prevention Trials Network 073. |
Q64136527 | Evaluation of self-report adherence measures and their associations with detectable viral load among people living with HIV (PLHIV) in China |
Q35916350 | Factors associated with non-adherence of adults infected with HIV on antiretroviral therapy in a referral hospital in Douala |
Q57476286 | Factors related to Adherence to Opioids in Black Patients with Cancer Pain |
Q33450648 | Feasibility and Acceptability of a Smartphone App for Daily Reports of Substance Use and Antiretroviral Therapy Adherence among HIV-Infected Adults |
Q89415217 | Fecal Coliform Bacterial Detection to Assess Enema Adherence in HIV Prevention Clinical Studies |
Q90682884 | Food insecurity is associated with lower levels of antiretroviral drug concentrations in hair among a cohort of women living with HIV in the United States |
Q48198008 | Health Behavior Change in Older Adults: Testing the Health Action Process Approach at the Inter- and Intraindividual Level. |
Q38994456 | Health care provider communication training in rural Tanzania empowers HIV-infected patients on antiretroviral therapy to discuss adherence problems |
Q47551904 | Higher Art Adherence is Associated with Lower Systemic Inflammation in Treatment-Naïve Ugandans Who Achieve Virologic Suppression |
Q37639074 | Housing Stability and Medication Adherence among HIV-Positive Individuals in Antiretroviral Therapy: A Meta-Analysis of Observational Studies in the United States. |
Q28078707 | How to Screen for Non-Adherence to Antihypertensive Therapy |
Q27318276 | Identification of evidence-based interventions for promoting HIV medication adherence: findings from a systematic review of U.S.-based studies, 1996-2011. |
Q57297481 | Identifying Risk of Viral Failure in Treated HIV-Infected Patients Using Different Measures of Adherence: The Antiretroviral Therapy Cohort Collaboration |
Q92073006 | Implementation of Medication Event Reminder Monitors among patients diagnosed with drug susceptible tuberculosis in rural Viet Nam: A qualitative study |
Q33787619 | Improving antiretroviral therapy adherence in resource-limited settings at scale: a discussion of interventions and recommendations |
Q94397641 | Measures of antiretroviral adherence for detecting viral non‐suppression in people living with HIV |
Q88884687 | Measuring adherence to antipsychotic medications for schizophrenia: Concordance and validity among a community sample in rural China |
Q47954113 | Measuring medication adherence in asthma: Development of a novel self-report tool. |
Q37031305 | Medication beliefs and structural barriers to treatment adherence among people living with HIV infection |
Q38197715 | Medicine non-adherence in kidney transplantation. |
Q38062882 | Methodological lessons from clinical trials and the future of microbicide research |
Q34337475 | Microbicide clinical trial adherence: insights for introduction |
Q47589574 | Mindfulness instruction for HIV-infected youth: a randomized controlled trial |
Q55210131 | Monitoring self-reported adherence to antiretroviral therapy in public HIV care facilities in Brazil: A national cross-sectional study. |
Q52323543 | Optimizing adherence in HIV prevention product trials: Development and psychometric evaluation of simple tools for screening and adherence counseling. |
Q27313352 | Patterns and correlates of PrEP drug detection among MSM and transgender women in the Global iPrEx Study |
Q92727139 | Performance of HIV pre-exposure prophylaxis indirect adherence measures among men who have sex with men and transgender women: Results from the PrEP Brasil Study |
Q99548133 | Performance of a short, self-report adherence scale in a probability sample of persons using HIV antiretroviral therapy in the United States |
Q52324625 | Pilot evaluation of a second-generation electronic pill box for adherence to Bedaquiline and antiretroviral therapy in drug-resistant TB/HIV co-infected patients in KwaZulu-Natal, South Africa. |
Q52642676 | Predicting short-term interruptions of antiretroviral therapy from summary adherence data: Development and test of a probability model. |
Q93383889 | Predictive validity of the Sidorkiewicz instrument in Spanish: Assessing individual drug adherence in psychiatric patients |
Q45740586 | Prescribing in prison: minimizing psychotropic drug diversion in correctional practice |
Q93135267 | Prevalence and determinants of adherence to antiretroviral treatment among HIV patients on first-line regimen: a cross-sectional study in Dakar, Senegal |
Q38903094 | Proposal of Standardization to Assess Adherence With Medication Records: Methodology Matters. |
Q55005002 | Rapid measures of user's adherence to vaginal drug products using attenuated total reflectance Fourier transform infrared spectroscopy (ATR-FTIR) and multivariate discriminant techniques. |
Q47121506 | Reaching the end of the line: Operational issues with implementing phone-based unannounced pill counts in resource-limited settings |
Q41021229 | Relationship between self-reported adherence, antiretroviral drug concentration measurement and self-reported symptoms in patients treated for HIV-1 infection. |
Q26775742 | Self-report measures of medication adherence behavior: recommendations on optimal use |
Q36994992 | Self-reported Recent PrEP Dosing and Drug Detection in an Open Label PrEP Study |
Q33798685 | State of the science of adherence in pre-exposure prophylaxis and microbicide trials |
Q33948938 | Study product adherence measurement in the iPrEx placebo-controlled trial: concordance with drug detection |
Q38918721 | The INCATM (Inhaler Compliance AssessmentTM): A comparison with established measures of adherence. |
Q41227413 | The Information and Motivation and Behavioral Skills Model of ART Adherence among HIV-Positive Adults in Mexico. |
Q33690506 | The development and validation of a method using high-resolution mass spectrometry (HRMS) for the qualitative detection of antiretroviral agents in human blood |
Q90074393 | Treatment Adherence Among Persons Receiving Concurrent Multidrug-Resistant Tuberculosis and HIV Treatment in KwaZulu-Natal, South Africa |
Q64081064 | Triggered Escalating Real-Time Adherence Intervention to Promote Rapid HIV Viral Suppression Among Youth Living With HIV Failing Antiretroviral Therapy: Protocol for a Triggered Escalating Real-Time Adherence Intervention |
Q33913873 | Validity of behavioral measures as proxies for HIV-related outcomes |